Correlation of N-myc downstream-regulated gene 1 expression with clinical outcomes of colorectal cancer patients of different race/ethnicity.

AIM To evaluate the role of N-myc downstream-regulated gene 1 (NDRG1) expression in prognosis and survival of colorectal cancer patients with different ethnic backgrounds. METHODS Because NDRG1 is a downstream target of p53 and hypoxia inducible factor-1 alpha (HIF-1 alpha), we examined NDRG1 expression together with p53 and HIF-1 alpha by immunohistochemistry. A total of 157 colorectal cancer specimens including 80 from Japanese patients and 77 from US patients were examined. The correlation between protein expression with clinicopathological features and survival after surgery was analyzed. RESULTS NDRG1 protein was significantly increased in colorectal tumor compared with normal epithelium in both Japanese and US patient groups. Expression of NDRG1 protein was significantly correlated with lymphatic invasion, venous invasion, depth of invasion, histopathological type, and Dukes' stage in Japanese colorectal cancer patients. NDRG1 expression was correlated to histopathological type, Dukes' stage and HIF-1 alpha expression in US-Caucasian patients but not in US-African American patients. Interestingly, Kaplan-Meier survival analysis demonstrated that NDRG1 expression correlated significantly with poorer survival in US-African American patients but not in other patient groups. However, in p53-positive US cases, NDRG1 positivity correlated significantly with better survival. In addition, NDRG1 expression also correlated significantly with improved survival in US patients with stages III and IV tumors without chemotherapy. In Japanese patients with stages II and III tumors, strong NDRG1 staining in p53-positive tumors correlated significantly with improved survival but negatively in patients without chemotherapy. CONCLUSION NDRG1 expression was correlated with various clinicopathological features and clinical outcomes in colorectal cancer depending on the race/ethnicity of the patients. NDRG1 may serve as a biological basis for the disparity of clinical outcomes of colorectal cancer patients with different ethnic backgrounds.

[1]  A. Stewart,et al.  Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation. , 2005, JAMA.

[2]  W. Barlow,et al.  Explaining black-white differences in receipt of recommended colon cancer treatment. , 2005, Journal of the National Cancer Institute.

[3]  O. Olopade,et al.  Colorectal cancer and race: understanding the differences in outcomes between African Americans and whites. , 2005, The Medical clinics of North America.

[4]  C. Cordon-Cardo,et al.  Drg1 Expression in 131 Colorectal Liver Metastases: Correlation with Clinical Variables and Patient Outcomes , 2005, Clinical Cancer Research.

[5]  M. Westfall,et al.  NDRG1 Is Necessary for p53-dependent Apoptosis* , 2004, Journal of Biological Chemistry.

[6]  Hakan Cangul,et al.  Hypoxia upregulates the expression of the NDRG1 gene leading to its overexpression in various human cancers , 2004, BMC Genetics.

[7]  Ken Saito,et al.  Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression , 2004, Oncogene.

[8]  F. Wang,et al.  Correlation of N-myc downstream-regulated gene 1 overexpression with progressive growth of colorectal neoplasm. , 2004, World journal of gastroenterology.

[9]  D. Polsky,et al.  Altered N-myc Downstream-Regulated Gene 1 Protein Expression in African-American Compared with Caucasian Prostate Cancer Patients , 2004, Clinical Cancer Research.

[10]  K. Miura,et al.  The Drg-1 gene suppresses tumor metastasis in prostate cancer. , 2003, Cancer research.

[11]  M. Blagosklonny,et al.  The Regulation of Hypoxic Genes by Calcium Involves c-Jun/AP-1, Which Cooperates with Hypoxia-Inducible Factor 1 in Response to Hypoxia , 2002, Molecular and Cellular Biology.

[12]  H. Schackert,et al.  Involvement of hMSH6 in the development of hereditary and sporadic colorectal cancer revealed by immunostaining is based on germline mutations, but rarely on somatic inactivation , 2002, International journal of cancer.

[13]  F. Larcher,et al.  Regulation of the differentiation‐related gene Drg‐1 during mouse skin carcinogenesis , 2001, Molecular carcinogenesis.

[14]  C. Graham,et al.  Hypoxia induces the expression of a 43-kDa protein (PROXY-1) in normal and malignant cells. , 2000, Biochemical and biophysical research communications.

[15]  H. Ford,et al.  Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. , 2000, Cancer research.

[16]  J. Swinnen,et al.  The differentiation‐related gene 1, Drg1, is markedly upregulated by androgens in LNCaP prostatic adenocarcinoma cells , 1999, FEBS letters.

[17]  T. Commes,et al.  Differential expression of the RTP/Drg1/Ndr1 gene product in proliferating and growth arrested cells. , 1999, Biochimica et biophysica acta.

[18]  H. Kondoh,et al.  N-myc-dependent repression of Ndr1, a gene identified by direct subtraction of whole mouse embryo cDNAs between wild type and N-myc mutant , 1999, Mechanisms of Development.

[19]  T. Miyata,et al.  Nonradioactive differential display cloning of genes induced by homocysteine in vascular endothelial cells. , 1998, Methods.

[20]  S. Aaronson,et al.  Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage. , 1998, Cancer research.

[21]  W. Dinjens,et al.  Expression of differentiation-related genes in colorectal cancer: possible implications for prognosis. , 1998, Histology and histopathology.

[22]  K. Salnikow,et al.  Cap43, a novel gene specifically induced by Ni2+ compounds. , 1998, Cancer research.

[23]  W. Dinjens,et al.  A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[24]  T. Miyata,et al.  Homocysteine-respondent Genes in Vascular Endothelial Cells Identified by Differential Display Analysis , 1996, The Journal of Biological Chemistry.

[25]  H. Yee,et al.  Enhanced Expression of a Novel Protein in Human Cancer Cells: A Potential Aid to Cancer Diagnosis , 2004, Cell Biology and Toxicology.

[26]  M. Blagosklonny,et al.  Carcinogenic nickel induces genes involved with hypoxic stress. , 2000, Cancer research.